Alligator Bioscience enters into Drug Development Collaboration

Alligator Bioscience AB has signed of a collaboration agreement with a major European drug company for the optimisation of a protein, using Alligator's proprietary ssDNA recombination technology, FIND.

According to the agreement Alligator Bioscience will receive milestone payments for the development as well as milestone payments during the clinical development of the final product.

Using the naturally occurring DNA sequence of a gene as a starting material, gene libraries consisting of millions of different variants of the gene are created using the FIND technology. Proteins corresponding to each of the variants are screened to identify improved protein variants and finally the optimal protein is selected.

For further information please contact:

Gun-Britt Fransson,

CEO

Tel: +46 46 286 42 80

Email: info@alligatorbioscience.com

Or visit: www.alligatorbioscience.com